Patent details

EP2760479 Title: NITROGEN SCAVENGING DRUG FOR USE IN A METHOD OF TREATING A NITROGEN RETENTION DISORDER

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2760479
WO Application Number:
US2012028620
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12835407.3
WO Publication Number:
WO2013048558
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
09/03/2012
Grant date:
03/05/2017
EP Publication Date:
06/08/2014
WO Publication Date:
04/04/2013
Claims Translations Received Date:
Claims Translation B1 Received Date:
26/07/2017
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
03/05/2017
EP B1 Publication Date:
03/05/2017
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
08/03/2032
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
24/12/2019
 
 

 

Name:
Immedica Pharma AB
Address:
Norrtullsgatan 15, 113 29, Stockholm, Sweden (SE)

Historical Applicant/holder

From:
24/12/2019
To:
24/12/2019

 

Name:
Medical Need Europe AB
Address:
Norrtullsgatan 15, 113 29, Stockholm, Sweden (SE)

From:
03/05/2017
To:
24/12/2019

 

Name:
Horizon Therapeutics, LLC
Address:
150 S. Saunders Rd., Lake Forest IL 60045, United States of America (US)

Domicile Holder

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
26/07/2017
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
SCHARSCHMIDT, Bruce
Address:
San Francisco California 94127, United States of America (US)

2

Name:
MOKHTARANI, Masoud
Address:
Walnut Creek California 94598, United States of America (US)

Priority

1

Priority Patent Number:
201161564668 P
Priority Date:
29/11/2011
Priority Country:
United States of America (US)

2

Priority Patent Number:
201161542100 P
Priority Date:
30/09/2011
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/216; A61K 31/235; G01N 33/49;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
53/19
Publication date:
01/01/2020
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
CO
Journal edition number:
53/19
Publication date:
01/01/2020
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
EP3
Journal edition number:
32/17
Publication date:
09/08/2017
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
18/17
Publication date:
03/05/2017
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201723
Publication date:
07/06/2017
Description:
Application number/publication number of the divisional application (Art. 76) changed

2

Issue number:
201718
Publication date:
03/05/2017
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201902630A
Date Registered:
24/12/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Medical Need Europe AB
Address:
Norrtullsgatan 15, 113 29, Stockholm, Sweden (SE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201902630B
Date Registered:
24/12/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Immedica Pharma AB
Address:
Norrtullsgatan 15, 113 29, Stockholm, Sweden (SE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/03/2026
Annual Fee Number:
15
Annual Fee Amount:
900 Euro
Last Annual Payment Date:
21/01/2025
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
800 Euro
Payer:
Zacco Sweden AB Patent Department
Filing date Document type Document Description Number of pages File Type
04/08/2017 Outgoing Correspondence Letter no formal defects 1 PDF /0/6/3/4/5/0800154360/docs/ep12835407.3_0_154321l271.pdf
26/07/2017 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /0/6/3/4/5/0800154360/docs/ep12835407.3_1_incomingcorrespondenceelectronic20170726120903317.pdf
26/07/2017 Claims First filed claims 1 PDF /0/6/3/4/5/0800154360/docs/ep12835407.3_2_claims20170726120902319.pdf